St. Jude Medical (STJ) Announces FDA Approval, U.S. Launch of Medical Device to Reduce Risk of Recurrent Ischemic Stroke in Patients with PFO

October 28, 2016 1:48 PM EDT Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced the U.S. Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login